Sponsor Pipeline

EyePoint Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
4
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07449936
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901…		 Trial sites expanded: 70 -> 73 locations
Active Trials by Phase
Phase 4
1
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05191706 Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery… Cataract Recruiting
Phase 3
NCT07449923 CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… Diabetic Macular Edema Recruiting
NCT07449936 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901… Diabetic Macular Edema Recruiting
NCT06668064 A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)… Wet Age Related Macular Degeneration Active, Not Recruiting
NCT06683742 A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)… Wet Age Related Macular Degeneration Active, Not Recruiting
Get alerts when EyePoint Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free